Acorda Therapeutics (ACOR) Tops Q2 EPS by 14c
Tweet
Share
E-mailGet Alerts ACOR Hot Sheet
Price: $0.66 --0%
Financial Fact:
Net loss per share-basic (earnings per share): -0.28
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Net loss per share-basic (earnings per share): -0.28
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Acorda Therapeutics (NASDAQ: ACOR) reported Q2 EPS of $0.31, $0.14 better than the analyst estimate of $0.17. Revenue for the quarter came in at $105.5 million versus the consensus estimate of $110.84 million.
For earnings history and earnings-related data on Acorda Therapeutics (ACOR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
- SanDisk upgraded at JPMorgan after investor day; shares climb
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
